Skip to main content

Resolution of alkaloid racemate: a novel microbial approach for the production of enantiopure lupanine via industrial wastewater valorization



Lupanine is a plant toxin contained in the wastewater of lupine bean processing industries, which could be used for semi-synthesis of various novel high added-value compounds. This paper introduces an environmental friendly process for microbial production of enantiopure lupanine.


Previously isolated P. putida LPK411, R. rhodochrous LPK211 and Rhodococcus sp. LPK311, holding the capacity to utilize lupanine as single carbon source, were employed as biocatalysts for resolution of racemic lupanine. All strains achieved high enantiomeric excess (ee) of L-(−)-lupanine (> 95%), while with the use of LPK411 53% of the initial racemate content was not removed. LPK411 fed with lupanine enantiomers as single substrates achieved 92% of D-(+)-lupanine biodegradation, whereas L-(−)-lupanine was not metabolized. Monitoring the transcriptional kinetics of the luh gene in cultures supplemented with the racemate as well as each of the enantiomers supported the enantioselectivity of LPK411 for D-(+)-lupanine biotransformation, while (trans)-6-oxooctahydro-1H-quinolizine-3-carboxylic acid was detected as final biodegradation product from D-(+)-lupanine use. Ecotoxicological assessment demonstrated that lupanine enantiomers were less toxic to A. fischeri compared to the racemate exhibiting synergistic interaction.


The biological chiral separation process of lupanine presented here constitutes an eco-friendly and low-cost alternative to widely used chemical methods for chiral separation.


The advanced performance of pure enantiomers as compared to chiral mixtures has stimulated a growing interest over the past few years in producing single isomer components for the food, fine chemicals, agrochemical and pharmaceutical sectors [1,2,3]. There is clear evidence of the advantage offered by the preparation of enantiomerically pure drugs, providing the required physiological effect, while reducing the total dose and side-effects caused by the undesired enantiomer [4]. Moreover, the production of enantiopure compounds exhibits strong economic interest and the worldwide sales of single-enantiomer drugs demonstrate a continuous increase [5]. Thus, different approaches have been developed for the production of pure enantiomers, comprising the asymmetric synthesis of a single enantiomer (chiral approach) and the resolution of racemic mixtures (racemic approach) [6].

Lupanine constitutes the major quinolizidine alkaloid present in the wastewater emitted from the manufacturing process of the L. albus L. snack [7, 8]. The aforementioned alkaloid has attracted considerable attention in the biotechnological sector and it could be employed as feedstock for semi-synthesis of various novel high added-value compounds based on a series of useful functionalities of its asymmetric structure [9]. However, lupanine is neurotoxic [10] and exists in nature in a racemate of D-(+)-lupanine and L-(−)-lupanine, necessitating the development of separation processes that recover the enantiomers in a pure form and enable the use of each compound for the production of specific fine molecules [11]. Only a few studies have currently achieved chemical resolution of racemic lupanine and conversion of lupanine enantiomers. Przybył and Kubicki, [12] produced optically pure lupanine enantiomers using dibenzoyltartaric acids followed by reduction of L-(−)-lupanine into D-(+)-sparteine, a naturally occurring compound which cannot be easily obtained from natural sources. Moreover, L-(−)-sparteine demonstrates numerous pharmacological properties and chemical applications as ligand or promoter for various asymmetric reactions [13], while the synthesis of D-(+)-sparteine exhibits increased industrial interest [14]. Thus, the production of L-(−)-lupanine from racemic lupanine rich wastewater through bioconversion is expected to open a novel direction for the synthesis of D-(+)-sparteine at a potentially lower cost.

Previous research has reported that different strains are capable of degrading racemic lupanine [15,16,17]. However, studies on microbial resolution of racemic alkaloids and the metabolic properties of the microorganisms employed are still lacking. Detheridge et al., [18] reported that the first step in lupanine catabolism using P. putida Psp-LUP employed hydroxylation of the alkaloid into 17-hydroxylupanine, which was catalysed by lupanine hydroxylase. The specific enzyme is active only when the microorganism is grown on D-(+)-lupanine remaining inactive at the presence of L-(−)-lupanine [19], which enables the selective resolution of the racemic mixture.

This work presents a simple, environmental friendly and safe biotechnological process that reduces the experimentation required for lupanine valorization through chemical methods for the manufacture of enantiopure alkaloids. Resolution of racemic lupanine was targeted through application of P. putida LPK411 and two Rhodococcus species capable of using lupanine as single carbon substrate. To this end, ee of L-(−)-lupanine was determined during growth on the racemic mixture by all three strains, while the capacity of LPK411 to utilize each of the enantiomers as single carbon substrates was also evaluated. The structure of the end-products formed from D-(+)-lupanine bioconversion was assessed by NMR and the toxicity of each enantiomer was evaluated using Aliivibrio fischeri. Additionally, expression from the gene encoding for the first enzyme of the pathway was systematically monitored during biodegradation of racemic lupanine and lupanine enantiomers to assess the enantioselective metabolic properties of LPK411.

Results and discussion

Biocatalytic resolution of lupanine enantiomeric mixture

Enantiomers comprise molecules that include the same chemical formula as well as identical physical and chemical properties in a chiral environment [3]. However, the biological activity of two enantiomers could be significantly different constituting the cost-effective enantioselective synthesis an important industrial topic [20]. Several processes have been employed for the manufacture of enantiopure compounds. The racemic approach includes processes of extensive industrial use, such as enantioselective liquid–liquid extraction, membrane applications and chromatography. However, employing these methods often requires use of expensive equipment and significant amounts of organic solvents [21]. Thus, biocatalytic resolution of racemic mixtures could be an environmental friendly and low cost alternative for chiral separation. In this study, the enantioselective degradation of racemic lupanine was investigated during fermentation of three microorganisms (P. putida LPK411, R. rhodochrous LPK211, Rhodococcus sp. LPK311), which are capable of utilizing racemic lupanine as single carbon substrate [15]. The results demonstrate that all microorganisms could perform resolution degrading faster D-(+)-lupanine (Fig. 1). LPK211 and LPK311 exhibited high resolution of racemic lupanine at 42 h, which corresponded to 100% and 98% of L-(−)-lupanine ee respectively. Moreover, approximately 60% of the initial racemic lupanine content still remained in the biomedium following 42 h at both cultures demonstrating that a substantial part of L-(−)-lupanine could still be potentially present. However, P. putida LPK411 reached L-(−)-lupanine ee of 95% more rapidly (36 h) as compared to Rhodococcus strains, which was further increased to 99% at 42 h. The remaining racemic lupanine from LPK411 cultivation at 36 h was 53% highlighting the great potential of the strain for biocatalytic L-(−)-lupanine purification.

Fig. 1

Biocatalytic resolution of racemic lupanine. a Biomass growth (OD), b lupanine concentration and c ee of L-(−)-lupanine (expressed as  %)

The literature has shown that Pseudomonas and Rhodococcus species are capable of biodegrading enantioselectively various compounds, including aromatic and other organic molecules (Table 1). Ettireddy et al. [22] reported that immobilized cells of P. putida (NCIB9494) were capable for resolution of racemic carvedilol within 10 h, accumulating (S)-(−)-carvedilol at a concentration of 34.92% and purity that included 94.67% ee. Furthermore, resting cells of Rhodococcus sp. CCZU10-1 could remove 44.7% of racemic phenyl methyl sulfoxide, achieving enantioselectivity of (S)-phenyl methyl sulfoxide that reached ee > 99.9% [23]. Resolution of racemic mixtures has been also achieved through the use of purified enzymes. Wu et al. [24] demonstrated that ω-transaminase from P. putida NBRC 14164 entailed high enantioselectivity to different racemic amines and amino alcohols, including α-methylbenzylamine and 2-amino-2-phenylethanol. The enzyme PpspuC achieved ee > 99.0% of (R)-α-methylbenzylamine and (S)-2-amino-2-phenylethanol within 4 h and 24 h respectively, while the removal of racemic α-methylbenzylamine was 50.2% and that of racemic 2-amino-2-phenylethanol reached 50.7%. Moreover, the oxidase R. opacus L-AAO incorporated wide substrate specificity and it was capable of performing resolution of racemic amino acid mixtures, including leucine and phenylalanine [25]. The results show that the purified enzyme achieved ee > 99.5% for d-phenylalanine and ee > 99.2% for d-leucine within 24 h, demonstrating that d-leucine and d-phenylalanine concentrations were constant during the process. However, Mesnard et al. [26] reported that in the presence of racemic nicotine, Nicotiana plumbaginifolia could degrade more rapidly (R)-nicotine as compared to the natural isomer (S)-nicotine. Thus far, studies have mainly focused on application of chemical methods for purification of lupanine enantiomers from the racemic mixture. Specifically, separation of the enantiomers could be achieved using solvents such as (+)-dibenzoyltartaric acid and ethanol in several steps [12, 13]. The findings of the present study suggest that a two stage process could be developed, including microbial resolution of racemic lupanine to produce enantiopure L-(−)-lupanine followed by chemical transformation of the latter into high added-value D-(+)-sparteine. Thus, the application of biocatalysts for lupanine racemate resolution could substantially reduce the experimentation required for achievement of a cost-effective process.

Table 1 Biocatalytic resolution of racemic mixtures

Biodegradation of lupanine enantiomers by P. putida LPK411

The most effective microorganism in performing racemic lupanine resolution was P. putida LPK411. Thus, the specific strain was grown in medium containing D-(+)-lupanine and L-(−)-lupanine, which were fed in separate cultures as single substrates (Fig. 2). The results demonstrate that only D-(+)-lupanine could be metabolized substantially by the microorganism. P. putida LPK411 achieved D-(+)-lupanine removal of 92% following 30 h of incubation, which resulted in net biomass production of 0.21 g L−1. Nevertheless, under the same conditions L-(−)-lupanine biodegradation was insignificant as confirmed by statistical analysis. Moreover, NMR was applied to identify the metabolites generated from D-(+)-lupanine biodegradation by P. putida LPK411 following 30 h of incubation. A single compound (molecule C3 in Fig. 2c) was formed as end-product of D-(+)-lupanine biodegradation, which was identified as (trans)-6-oxooctahydro-1H-quinolizine-3-carboxylic acid.

Fig. 2

Biodegradation of D-(+)-lupanine and L-(−)-lupanine by P. putida LPK411. a Biomass growth (dry cell weight concentration), b concentration of D-(+)-lupanine and L-(−)-lupanine in fermentations, c chemical structure of lupanine enantiomers and end-product formed from D-(+)-lupanine biodegradation. C1: D-(+)-lupanine; C2: L-(−)-lupanine; C3: (trans)-6-oxooctahydro-1H-quinolizine-3-carboxylic acid

A few studies have focused on biodegradation of racemic quinolizidine alkaloid mixtures, while significantly less attention has been placed in biodegradation of other racemic alkaloids. Hopper and Kaderbhai, [19] suggested that the first step of lupanine biodegradation by Pseudomonas sp. occurred through the action of lupanine hydroxylase, an inducible enzyme which was active only when the microorganism was grown on D-(+)-lupanine. The enzyme remained inactive in the presence of L-(−)-lupanine indicating that it could be induced only by growth of the strain on D-(+)-lupanine. Santana et al. [17] demonstrated that the molecules 3-hydroxylupanine, 13-hydroxylupanine, 17-oxosparteine, 3,4-dehydrolupanine and α-isolupanine can be produced during lupanine bioconversion by unidentified microorganisms. Moreover, bioconversion experiments of racemic lupanine using LPK111 and LPK311 generated the same compound (lupanine N-oxide) as final metabolic product [15]. However, the use of P. putida LPK411 resulted in accumulation of three metabolic products from racemic lupanine biodegradation (17-oxolupanine and two derivatives incorporating open ring structures). The final metabolic product of D-(+)-lupanine biodegradation by P. putida LPK411 identified in the current study has not been previously reported as a metabolite from microbial cultivation on lupanine. However, the presence of the amide and carboxyl functionalities opens the possibility for further chemoselective functional group modifications. Thus, further research is needed to assess the complete metabolic pathway followed by LPK411 for D-(+)-lupanine biodegradation and the potential use of the specific molecule as starting material for chemical synthesis of other valuable products [27].

Transcriptional kinetics of luh gene in P. putida LPK411

An increased research interest over the past few years in understanding and optimizing the production of added-value commodities by microbial producers has stimulated various studies pertinent to the metabolism of quinolizidine alkaloids, including lupanine and sparteine [18, 19]. Determination of transcriptional kinetics in microorganisms enables obtaining important information pertinent to the expression of catabolic genes improving the knowledge about waste streams bioconversion to high added-value chemicals and the biodegradation process triggered [28]. Moreover, future optimization of the bioprocess is enabled through the development of coupled gene expression-growth kinetic models [29, 30].

The first step in racemic lupanine biodegradation by Pseudomonas sp. was performed via the action of the luh gene, which encodes for the lupanine hydroxylase enzyme responsible for the conversion of lupanine to 17-hydroxylupanine [19, 31]. Thus, luh could be the first gene expressed in the catabolic pathway of lupanine used by LPK411. Herein, systematic monitoring of transcription from the luh gene was performed during the course of P. putida LPK411 growth in medium containing the racemic alkaloid mixture or lupanine enantiomers (D-(+)-lupanine, L-(−)-lupanine) until biomass reached the stationary phase (Fig. 3). mRNA expression of luh was at basal level upon racemic lupanine entry, while at the first stages of the culture luh transcription continuously increased (p < 0.05) reaching a peak of expression at 6 h. The direct decrease of lupanine concentration observed since the beginning of the culture supported this claim. Thus, the maximal expression of luh occurred at the onset of exponential growth, where racemic lupanine biodegradation had already started, suggesting complete activation of the lupanine biodegradation pathway. Subsequently, luh mRNA expression was reduced to basal levels between 12 and 15 h (p < 0.05), where racemic lupanine removal reached 57%. Similarly to racemic lupanine biodegradation, the addition of D-(+)-lupanine triggered the same response of luh transcription demonstrating similar mRNA expression pattern (p < 0.05). The only difference was identified at 15 h of fermentation where luh expression due to D-(+)-lupanine catabolism was significantly higher as compared to expression triggered by racemic lupanine. Interestingly, luh was not expressed immediately following L-(−)-lupanine addition remaining at basal level for the first h of substrate induction. However, expression of luh sharply increased following 6 h of enantiomer addition exhibiting similar mRNA level as compared to the use of racemic and D-(+)-lupanine (p < 0.05). Although expression from the catabolic gene was activated with the use of L-(−)-lupanine, which was not biodegraded in the experiment, luh mRNA was decreased to basal level for the rest of the culture.

Fig. 3

Expression from the luh gene of P. putida LPK411 during biodegradation of racemic lupanine and lupanine enantiomers. a Biomass growth (dry cell weight), b concentration of racemic lupanine and lupanine enantiomers and cluh gene relative mRNA expression

The response of luh upon exposure to lupanine enantiomers and the racemic mixture indicates stimulation of the gene by all the molecules used. However, although these results confirm production of the precursor mRNA molecules required for lupanine hydroxylase formation, which catalyses lupanine bioconversion to the first intermediate of the metabolic pathway, L-(−)-lupanine was not biodegraded. Thus, given that the gene is transcribed in the presence of L-(−)-lupanine either the translation process or the activation of lupanine hydroxylase cannot proceed due to the environmental signal preventing its biodegradation. Moreover, the delay of luh activation in the culture conducted using L-(−)-lupanine as compared to the cultures supplemented with D-(+)-lupanine and the racemate indicate that an alternative gene activation mechanism could be potentially followed in the presence of L-(−)-lupanine.

A limited number of publications have focused on the microbial metabolism of quanolizidine alkaloids. Detheridge et al. [18] demonstrated that the initial step in lupanine and sparteine degradation was performed through hydroxylation on carbon C-17 by hydroxylase and dehydrogenase enzymes respectively. Moreover, lupanine hydroxylase was active in P. putida only when D-(+)-lupanine was supplemented [19]. Previous studies exhibited that lupanine dehydrogenase from P. lupanini is a stereospecific enzyme which catalyses only D-(+)-lupanine [32, 33]. According to Adamu et al. [34] stereospecific/stereoselective enzymes recognize and bind to a specific enantiomeric substrate. The present study further supports this claim through monitoring of luh transcriptional kinetics, confirming for the first time that luh mRNA gene expression is triggered by the racemate and both lupanine enantiomers, which supports the potential stereospecificity of lupanine catabolic enzymes. Nevertheless, further research is necessary to decipher the molecular events that control the catabolic route of the specific alkaloid.

Toxicological assessment of lupanine enantiomers with marine bacteria

The marine bacterial strain A. fischeri constitutes a microorganism that is commonly employed in microscale toxicity testing, based on its natural bioluminescence capacity. Therefore, the particular ecotoxicological bioassay was applied to assess the acute toxicity of each lupanine enantiomer. The toxicity imposed on the aquatic microorganism was calculated as the EC50 value corresponding to two distinct durations of exposure to each enantiomer (Additional file 1: Fig. S1). Τhe toxicological assessment demonstrates that both D-(+)-lupanine and L-(−)-lupanine induced similar levels of toxicity for Α. fischeri, based on EC50 values obtained for 5 min and 15 min of exposure that ranged between 317–320 mg L−1 and 372–457 mg L−1 respectively. Moreover, the enantiomers interaction assessment (Fig. 4) demonstrates a very strong synergistic effect of D-(+)-lupanine and L-(−)-lupanine mixture toxicity for Α. fischeri (CI < 1).

Fig. 4

Ecotoxicological assessment of racemate and lupanine enantiomers on Α. fischeri. a Bioluminescence inhibition for 5 min of exposure, b bioluminescence inhibition for 15 min of exposure and c toxicity interaction (expressed as CI) values calculated for different durations of exposure to the alkaloid

Previous studies on intravenous administration of coniine, ammodendrine and N-methylammodendrine enantiomers in mice demonstrated that the two molecules can incorporate similar LD50 values, which could be similar to that of the racemic mixture (Table 2). Moreover, the toxicity of the racemate often constitutes the additive result of both enantiomers, demonstrating an effect that ranges between the toxicity values of the respective enantiomers [35]. However, ecotoxicological studies in mice report that racemic anabasine expressed higher toxicity as compared to the enantiomers [36]. The EC50 values calculated for racemic lupanine on Α. fischeri have been previously determined for 5 min and 15 min of exposure as 89 mg L−1 and 47 mg L−1 respectively [15]. Thus, the results presented here indicate that lupanine enantiomers are less toxic as compared to racemic lupanine, confirming the presence of a strong synergistic effect in the toxicity action of these molecules when they exist in the form of a racemic mixture. This response is aligned with a potential absence of a specific mechanism for detoxification/transformation of these compounds in the metabolism of A. fischeri, that could result in at least additive effect on bioluminescence inhibition following exposure to the racemic mixture. Lin et al. [37] reported that enantioselective biological reactions, such as in vivo chiral inversion or enantiomerization, could cause antagonistic or synergistic interactions. Nevertheless, only a few studies have yet attempted to understand the interactions between the enantiomers of chiral molecules.

Table 2 Ecotoxicological effects of racemic mixtures and the respective enantiomers in different organisms


Biocatalytic resolution of the lupanine racemate existing in alkaloid rich wastewater could provide an innovative technology for production of useful molecules improving the sustainability of current chemical methods and decrease the ecotoxicological effect of the specific effluent. The microorganisms employed achieved high L-(−)-lupanine excess and the enantioselectivity of LPK411 for D-(+)-lupanine was shown in fermentations through measurements of macroscopic process parameters and via monitoring the transcriptional kinetics of luh aiming to decipher the molecular interactions responsible for lupanine enantioselective catabolism. The data obtained hold great potential for development of an environmental friendly biological chiral separation process of lupanine, which could be combined with chemical modification methods to produce a range of added-value molecules.

Materials and methods

Purification of lupanine racemate and enantiomers

Racemic and enantiopure lupanine was obtained following a procedure previously described [13, 15]. The purity of lupanine isolated from the above processes was also determined by 1H NMR spectroscopy. There were no detectable differences between the respective protons of D-(+)-lupanine and L-(−)-lupanine isomers, since they produce identical chemical shifts. However, impurities assigned to multiflorine were detected in the racemic mixture of lupanine up to 7%, whereas in each specific isolated enantiomeric product D-(+)-lupanine or L-(−)-lupanine, isomer impurities assigned to various quinolizidine derivatives based on the integrals of the protons bound to the unsaturated carbons were quantified up to 4%.

Microorganisms and culture conditions

All microorganisms used were isolated as presented in Parmaki et al. [15] and they were maintained as glycerol stock preparations at − 80 °C. Subcultures of P. putida LPK411 and two Rhodococcus strains (R. rhodochrous LPK211, Rhodococcus sp. LPK311) were pregrown at 31 °C in M9 minimal salts medium overnight using 1.5 g L−1 of lupanine racemate as carbon source. The inoculum was grown in 250 mL flasks with a working volume of 50 mL under 100 rpm stirring. Duplicate cultures were prepared under sterile conditions with the addition of 5% (v/v) inoculum volume utilizing racemic lupanine as well as pure lupanine enantiomers (D-(+)-lupanine or L-(−)-lupanine) depending on the requirements of each experiment.

Cultures for biocatalytic resolution of lupanine racemate were conducted through application of 1.5 g L−1 racemic lupanine in 500 mL flasks (working volume of 300 mL) and 5% (v/v) of inoculum. For biodegradation of lupanine enantiomers 7.5 mL of pregrown cells were inoculated into 500 mL flasks (working volume 150 mL) containing M9 medium with initial D-(+)-lupanine or L-(−)-lupanine concentration of 0.75 g L−1.

Subcultures of P. putida LPK411 for determination of transcriptional kinetics of luh gene were pregrown for 18 h at 31 °C in M9 supplemented with 1.5 g L−1 of succinic acid. The experiments were prepared by diluting pregrown cells in M9 containing 1.5 g L−1 racemic lupanine or 0.75 g L−1 lupanine enantiomers (either D-(+)-lupanine or L-(−)-lupanine). The optical density (600 nm) at the beginning of the experiment was 0.1 measured on a UV/VIS spectrophotometer (JENWAY 7315, Staffordshire, UK), while cultivation was conducted using 1000 mL shake flasks (200 mL working volume). All experiments were performed at 31 °C, 100 rpm and pH 7.

Acute toxicity assessment of lupanine enantiomers with marine bacteria

Bioluminescence inhibition of the marine bacteria Aliivibrio fischeri (ΝRRL Β11177) following exposure to each lupanine enantiomer (D-(+)-lupanine or L-(−)-lupanine) was assessed employing an acute toxicity microscale test as described previously [15]. Several dilutions that varied between 75 and 1000 mg L−1 were prepared using stock solutions of each lupanine enantiomer and 2% NaCl of final salinity, while the pH ranged from 7 to 7.5. Lyophilized bacteria were rehydrated with reconstitution solution and maintained at 15 °C throughout the test.

Luminescence of bacteria was measured following exposure to lupanine enantiomers for 0, 5 and 15 min using a Microtox Model 500 analyzer (Newark DE, USA). Triplicate preparations of each experimental run were conducted and the samples collected were analyzed in duplicate. The compound applied as positive control was phenol. The concentration resulting in population bioluminescence inhibition of 50% (EC50) was calculated using linear regression of inhibition as previously presented [15].

Toxicity interaction assessment of lupanine enantiomeric mixture

Combination index (CI) analysis was conducted to quantify the effect of the lupanine binary mixture using CompuSyn software (Combo-Syn Inc., US). CI values calculation was conducted as previously described in Chou, [40]. Toxicity interaction of the mixture was classified as (i) synergism: CI < 1, (ii) additive effect: CI = 1, and (iii) antagonism: CI > 1.

Preparation and isolation of total RNA, cDNA synthesis and quantitative real-time PCR (q-PCR)

q-PCR analysis was conducted to measure mRNA expression from the luh gene during racemic lupanine biodegradation by P. putida LPK411. Depending on the cell density 3–4.5 mL samples were collected and centrifuged at 9000 rpm for 30 min at 4 °C. The harvested cell pellet was soaked in liquid nitrogen and subsequently stored at − 80 °C. Total RNA isolation and cDNA synthesis were performed as previously described [41]. According to the threshold cycle values obtained relative mRNA expression was estimated using Eq. 1. cDNA synthesis and qPCR were performed using a SensoQuest labcycler (SensoQuest GmbH, Göttingen, Germany) and qTower3G real-time PCR (Analytik Jena, Jena, Germany) respectively. The primer pairs of the luh and rpoN, which was used as the reference gene, are displayed in additional data (Additional file 1: Table S1). Duplicate experiments were conducted and two samples were analysed for each replicate comprising analysis of 4 samples in each time point.

$$\Delta {\text{C}}_{{{\text{T}},luh}} = {\text{C}}_{{{\text{T}},rpoN}} - {\text{C}}_{{{\text{T}},luh}}$$

Statistical analysis of mRNA expression data

The objective of statistical analysis was to elucidate the relative mRNA expression profile of luh gene. Thus, one-way analysis of variance (ANOVA) was conducted and p < 0.05 was defined as acceptable level of significance.

Analytical methods

Dry cell weight

A UV/VIS spectrophotometer (JENWAY 7315, Staffordshire, UK) was used to measure biomass absorbance (600 nm) and dry biomass was determined using a calibration curve of dry cell weight. The calibration was obtained through dilution of a pre-grown culture to obtain different OD values. Biomedium samples of 10 mL were dried (105 °C) and placed at 600 °C for 60 min to combust the organic content. The coefficient of variation calculated for 3 samples was 4.5% at a biomass content of 0.1 gbiomass L−1.

Determination of lupanine concentration

Gas Chromatograph (GC) analysis was performed to access the racemic and lupanine enantiomers content in samples derived from microbial cultures as previously described [15]. All substances applied were analytical grade and purchased from Sigma-Aldrich Company Ltd (UK).

Determination of lupanine ee

High Performance Liquid Chromatography (HPLC) was applied to assess the lupanine enantiomeric excess in microbial cultures. Samples were centrifuged at 4500 rpm and filtered through 0.2 μm syringe filters for biomass removal. 15 mL of the filtrate were basified (pH > 11) using 1 M NaOH solution and the alkaloid content was extracted with application of 40 mL of dichloromethane. Drying of the organic phase was performed with anhydrous Na2SO4 and subsequent concentration was achieved using a Rotavapor R-3 (BUCHI Labortechnik, Switzerland). Concentrate sample was applied to a pipette containing Celite and the alkaloid content was eluted through application of 4–6 mL dichloromethane. The samples were evaporated until dry and dissolved in 100 μL isopropanol, to which 900 μL of n-hexane was added. HPLC analysis was performed using a 4.6 mm × 250 mm × 5 μm CHIRALPAK IC column (Chiral Technologies Inc., West Chester, PA, USA) and a 10 mm guard column. The mobile phase constituted 53% n-hexane, 22% isopropanol and 25% n-hexane with 0.1% of diethylamine. A flow rate of 1 mL min−1 was used, while the method was conducted at room temperature and UV detection (230 nm). Analytical grade chemicals were used at all times.

Metabolic products’ identification

Nuclear magnetic resonance spectroscopy (NMR) was employed to identify the metabolites formed as end-products of lupanine enantiomers biodegradation as described in Parmaki et al. [15].

Availability of data and materials

All data generated or analysed during this study are included in this published article and its additional information files.



Analysis of variance


Combination index

EC50 :

Half maximal effective concentration


Enantiomeric excess


Gas chromatograph


Intravenous administration

LD50 :

Lethal dose


Nuclear magnetic resonance


Optical density


Quantitative real-time PCR


  1. 1.

    Leek H, Andersson S. Preparative scale resolution of enantiomers enables accelerated drug discovery and development. Molecules. 2017;22(1):158.

    PubMed Central  Article  Google Scholar 

  2. 2.

    Blaser HU. Looking back on 35 years of industrial catalysis. Chimia. 2015;69(7–8):393–406.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Fanali C, D’Orazio G, Gentili A, Fanali S. Analysis of enantiomers in products of food interest. Molecules. 2019;24(6):1119.

    CAS  PubMed Central  Article  Google Scholar 

  4. 4.

    Calcaterra A, D’Acquarica I. The market of chiral drugs: chiral switches versus de novo enantiomerically pure compounds. J Pharm Biomed Anal. 2018;147:323–40.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Sanganyado E, Lu Z, Fu Q, Schlenk D, Gan J. Chiral pharmaceuticals: a review on their environmental occurrence and fate processes. Water Res. 2017;124:527–42.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Rossi D, Tarantino M, Rossino G, Rui M, Juza M, Rossi D. Approaches for multi-gram scale isolation of enantiomers for drug discovery. Expert Opin Drug Discov. 2017;12(12):1253–69.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Miano AC, Rojas ML, Augusto PED. Using ultrasound for improving hydration and debittering of Andean lupin grains. J Food Process Eng. 2019;42(6):e13170.

    Article  Google Scholar 

  8. 8.

    Kroc M, Rybiński W, Wilczura P, Kamel K, Kaczmarek Z, Paweł B, et al. Quantitative and qualitative analysis of alkaloids composition in the seeds of a white lupin (Lupinus albus L.) collection. Genet Resour Crop Evol. 2017;64(8):1853–60.

    CAS  Article  Google Scholar 

  9. 9.

    Villalpando-Vargas F, Medina-Ceja L. Sparteine as an anticonvulsant drug: evidence and possible mechanism of action. Seizure. 2016;39:49–55.

    PubMed  Article  Google Scholar 

  10. 10.

    Wink M. Quinolizidine and pyrrolizidine alkaloid chemical ecology—a mini-review on their similarities and differences. J Chem Ecol. 2019;45:109–15.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Gumustas M, Ozkan SA, Chankvetadze B. Analytical and preparative scale separation of enantiomers of chiral crugs by chromatography and related methods. Curr Med Chem. 2018;25(33):4152–88.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Przybył AK, Kubicki M. Simple and highly efficient preparation and characterization of (−)-lupanine and (+)-sparteine. Tetrahedron. 2011;67(40):7787–93.

    Article  Google Scholar 

  13. 13.

    Maulide N, Peng B, Afonso CAM, Frade RF. Process for converting lupanine into sparteine. U.S. Patent No. 9,388,182. Washington, DC: U.S. Patent and Trademark Office. Washington, DC; 9,388,182, 2016.

  14. 14.

    Firth JD, Canipa SJ, Ferris L, O’Brien P. Gram-scale synthesis of the (−)-sparteine surrogate and (−)-sparteine. Angew Chemie Int Ed. 2018;57:223–6.

    CAS  Article  Google Scholar 

  15. 15.

    Parmaki S, Vyrides I, Vasquez MI, Hartman V, Zacharia I, Hadjiadamou I, et al. Bioconversion of alkaloids to high-value chemicals: comparative analysis of newly isolated lupanine degrading strains. Chemosphere. 2018;193:50–9.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Hopper DJ, Rogozinski J, Toczko M. Lupanine hydroxylase, a quinocytochrome c from an alkaloid-degrading Pseudomonas sp. Biochem J. 1991;279(1):105–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Santana FM, Pinto T, Fialho AM, Sá-Correia I, Empis JM. Bacterial removal of quinolizidine alkaloids and other carbon sources from a Lupinus albus aqueous extract. J Agric Food Chem. 2002;50(8):2318–23.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Detheridge AP, Griffith GW, Hopper DJ. Genome sequence analysis of two Pseudomonas putida strains to identify a 17-hydroxylase putatively involved in sparteine degradation. Curr Microbiol. 2018;75(12):1649–54.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Hopper DJ, Kaderbhai MA. The quinohaemoprotein lupanine hydroxylase from Pseudomonas putida. Biochim Biophys Acta. 2003;1647(1):110–5.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Casado N, Valimaña-Traverso J, García MÁ, Marina ML. Enantiomeric determination of drugs in pharmaceutical formulations and biological samples by electrokinetic chromatography. Crit Rev Anal Chem. 2019.

    PubMed  Article  Google Scholar 

  21. 21.

    Yuan X, Wang L, Liu G, Dai G, Tang K. Resolution of (R, S)-ibuprofen catalyzed by immobilized Novozym40086 in organic phase. Chirality. 2019;31(6):445–56.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Ettireddy S, Chandupatla V, Veeresham C. Enantioselective resolution of (R, S)-carvedilol to (S)-(−)-carvedilol by biocatalysts. Nat Products Bioprospect. 2017;7:171–9.

    CAS  Article  Google Scholar 

  23. 23.

    He YC, Ma CL, Yang ZX, Zhou M, Xing Z, Ma JT, et al. Highly enantioselective oxidation of phenyl methyl sulfide and its derivatives into optically pure (S)-sulfoxides with Rhodococcus sp. CCZU10-1 in an n-octane–water biphasic system. Appl Microbiol Biotechnol. 2013;97(24):10329–37.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Wu HL, Zhang JD, Zhang CF, Fan XJ, Chang HH, Wei WL. Characterization of four new distinct ω-transaminases from Pseudomonas putida NBRC 14164 for kinetic resolution of racemic amines and amino alcohols. Appl Biochem Biotechnol. 2017;181:972–85.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Geueke B, Hummel W. A new bacterial L-amino acid oxidase with a broad substrate specificity: purification and characterization. Enzyme Microb Technol. 2002;31(1–2):77–87.

    CAS  Article  Google Scholar 

  26. 26.

    Mesnard F, Girard S, Fliniaux O, Bhogal RK, Gillet F, Lebreton J, et al. Chiral specificity of the degradation of nicotine by Nicotiana plumbaginifolia cell suspension cultures. Plant Sci. 2001;161(5):1011–8.

    CAS  Article  Google Scholar 

  27. 27.

    Smitha MS, Singh S, Singh R. Microbial biotransformation: a process for chemical alterations. J Bacteriol Mycol Open Access. 2017;4(2):85.

    Google Scholar 

  28. 28.

    Tsipa A, Koutinas M, Pistikopoulos EN, Mantalaris A. Transcriptional kinetics of the cross-talk between the ortho-cleavage and TOL pathways of toluene biodegradation in Pseudomonas putida mt-2. J Biotechnol. 2016;228:112–23.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Tsipa A, Koutinas M, Usaku C, Mantalaris A. Optimal bioprocess design through a gene regulatory network-Growth kinetic hybrid model: towards replacing Monod kinetics. Metab Eng. 2018;48:129–37.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Koutinas M, Kiparissides A, Lam MC, Silva-Rocha R, Godinho M, de Lorenzo V, et al. Improving the prediction of Pseudomonas putida mt-2 growth kinetics with the use of a gene expression regulation model of the TOL plasmid. Biochem Eng J. 2011;55(2):108–18.

    CAS  Article  Google Scholar 

  31. 31.

    Hopper DJ, Kaderbhai MA, Marriott SA, Young M, Rogozinski J. Cloning, sequencing and heterologous expression of the gene for lupanine hydroxylase, a quinocytochrome c from a Pseudomonas sp. Biochem J. 2002;367(2):483–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Niedzielska A, Rogozinski J. Inducible lupanine hydroxylase from resting culture of Pseudomonas lupanini. Bull Acad Pol Sci Biol. 1973;21(1):1–5.

    CAS  Google Scholar 

  33. 33.

    Toczko M. Induced lupanine hydroxylase from Pseudomonas lupanini. Biochim Biophys Acta (BBA)-Enzymology Biol Oxid. 1966;128(3):570–3.

    CAS  Google Scholar 

  34. 34.

    Adamu A, Firdausi A, Huyop F, Wahab RA. Molecular basis and engineering of enzymes stereospecificity. J Mol Biol Methods. 2018;1(1):1–7.

    Google Scholar 

  35. 35.

    Zhou S, Lin K, Li L, Jin M, Ye J, Liu W. Separation and toxicity of salithion enantiomers. Chirality. 2009;21(10):922–8.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Green BT, Lee ST, Panter KE, Brown DR. Piperidine alkaloids: human and food animal teratogens. Food Chem Toxicol. 2012;50:2049–55.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Lin K, Liu W, Li L, Gan J. Single and joint acute toxicity of isocarbophos enantiomers to Daphnia magna. J Agric Food Chem. 2008;56(11):4273–7.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Lee ST, Green BT, Welch KD, Jordan GT, Zhang Q, Panter KE, et al. Stereoselective potencies and relative toxicities of γ-coniceine and N-methylconiine enantiomers. Chem Res Toxicol. 2013;26:616–21.

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Lee ST, Molyneux RJ, Panter KE, Chang CWT, Gardner DR, Pfister JA, et al. Ammodendrine and N-methylammodendrine enantiomers: isolation, optical rotation, and toxicity. J Nat Prod. 2005;68(5):681–5.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Chou TC. Drug combination studies and their synergy quantification using the Chou–Talalay method. Cancer Res. 2010;70(2):440–6.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Koutinas M, Lam MC, Kiparissides A, Silva-Rocha R, Godinho M, Livingston AG, et al. The regulatory logic of m-xylene biodegradation by Pseudomonas putida mt-2 exposed by dynamic modelling of the principal node Ps/Pr of the TOL plasmid. Environ Microbiol. 2010;12(6):1705–18.

    CAS  PubMed  Article  Google Scholar 

Download references


Not applicable.


This work was supported by the M-ERA.NET project Biorg4WasteWaterVal + co-funded by the Research Promotion Foundation (RPF, Cyprus) [Grant Number ΚΟΙΝΑ/ΠΚΠ-WATER/0315/14]; and the Fundação para a Ciência e a Tecnologia (FCT, Portugal) [Grant Numbers WaterJPI/0001/2014, WaterJPI/0002/2014, WaterJPI/0003/2014].

Author information




SP and MK designed the work. SP performed the main experiments and analysis, including fermentation experiments, toxicological tests, q-PCR analysis, GC-FID analysis and statistical analysis. JMJG and CAMA produced purified lupanine racemate and enantiomers and performed HPLC analysis. MIV supervised toxicological tests and performed toxicity interaction assessment. AT designed and participated in q-PCR experiments and statistical analysis. IH and CD performed NMR analysis. SP analysed the literature, experimental data and prepared the manuscript with help of MK and FCF. MK supervised the work. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Michalis Koutinas.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Parmaki, S., Tsipa, A., Vasquez, M.I. et al. Resolution of alkaloid racemate: a novel microbial approach for the production of enantiopure lupanine via industrial wastewater valorization. Microb Cell Fact 19, 67 (2020).

Download citation


  • Lupanine
  • Enantiomers
  • Enantiomeric excess
  • Ecotoxicological assessment
  • Pseudomonas putida LPK411
  • Quantitative real-time PCR
  • Gene expression